New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients

Aim. To describe the antihypertensive efficacy of triple fixed­dose combination of amlodipine/indapamide/perindopril and assess the predictors of efficacy in young patients (<50 years).Material and methods. The TRICOLOR study (NCT03722524) is an observational prospective study (n=1247) that d...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. A. Karpov, N. A. Logunova, B. B. Kvasnikov, Yu. V. Khomitskaya
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-11-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5597
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849341444122214400
author Yu. A. Karpov
N. A. Logunova
B. B. Kvasnikov
Yu. V. Khomitskaya
author_facet Yu. A. Karpov
N. A. Logunova
B. B. Kvasnikov
Yu. V. Khomitskaya
author_sort Yu. A. Karpov
collection DOAJ
description Aim. To describe the antihypertensive efficacy of triple fixed­dose combination of amlodipine/indapamide/perindopril and assess the predictors of efficacy in young patients (<50 years).Material and methods. The TRICOLOR study (NCT03722524) is an observational prospective study (n=1247) that demonstrated high antihypertensive effectiveness and good tolerability of the triple single­pill combination (SPC) of amlodipine/ indapamide/perindopril. This subgroup analysis was performed on 199 patients aged <50 years (16% of the total population), and the comparison group consisted of 925 patients (82,3% of the total population) aged 50 years or older.Results. In young patients, during triple therapy with SPC amlodipine/indapa­ mide/perindopril, a positive trend in blood pressure (BP) reduction was observed compared to the baseline: an average decrease in BP after 12 weeks was 32,6 (11,0)/14,8 (8,5) mm Hg (p<0,0001), comparable to patients over 50 years of age in terms of reduction in systolic blood pressure (SBP) and diastolic blood pressure (DBP) after 2, 4 and 12 weeks of follow­up. A greater number of young patients achieved a reduction in blood pressure <140/90 mm Hg after 2 weeks of therapy compared to patients 50 years of age and older (49,7% vs 38,8%, p=0,004), and blood pressure <130/80 mm Hg – after 4 and 12 weeks (51,3% vs 43,5% (p=0,041) and 74,9% vs 67,5% (p=0,038), respectively). Left ventricular hypertrophy was a significant negative predictor of SBP reduction by 12 weeks of therapy, and the presence of grade 2 hypertension (HTN) and statin use, on the contrary, were positive predictors of changes in SBP by the end of observation. More adherent younger patients were significantly more likely to have a decrease in DBP by 12 weeks of follow-up. In addition, in young patients, male sex and the presence of dyslipidemia significantly increased the chances of blood pressure control at the end of observation. Waist circumference, body mass index, and grade 2 HTN were negative predictors of achieving the target blood pressure level.Conclusion. Thus, in young patients, good antihypertensive effectiveness of amlodipine/indapamide/perindopril was observed, comparable in the degree of blood pressure reduction with the older age group of 50 years and older.
format Article
id doaj-art-869c98b9e498493bb7f9b78c49e8e87c
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2023-11-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-869c98b9e498493bb7f9b78c49e8e87c2025-08-20T03:43:37Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-11-01281010.15829/1560-4071-2023-55973914New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patientsYu. A. Karpov0N. A. Logunova1B. B. Kvasnikov2Yu. V. Khomitskaya3E. I. Chazov National Medical Research Center of CardiologyServier companyServier companyServier companyAim. To describe the antihypertensive efficacy of triple fixed­dose combination of amlodipine/indapamide/perindopril and assess the predictors of efficacy in young patients (<50 years).Material and methods. The TRICOLOR study (NCT03722524) is an observational prospective study (n=1247) that demonstrated high antihypertensive effectiveness and good tolerability of the triple single­pill combination (SPC) of amlodipine/ indapamide/perindopril. This subgroup analysis was performed on 199 patients aged <50 years (16% of the total population), and the comparison group consisted of 925 patients (82,3% of the total population) aged 50 years or older.Results. In young patients, during triple therapy with SPC amlodipine/indapa­ mide/perindopril, a positive trend in blood pressure (BP) reduction was observed compared to the baseline: an average decrease in BP after 12 weeks was 32,6 (11,0)/14,8 (8,5) mm Hg (p<0,0001), comparable to patients over 50 years of age in terms of reduction in systolic blood pressure (SBP) and diastolic blood pressure (DBP) after 2, 4 and 12 weeks of follow­up. A greater number of young patients achieved a reduction in blood pressure <140/90 mm Hg after 2 weeks of therapy compared to patients 50 years of age and older (49,7% vs 38,8%, p=0,004), and blood pressure <130/80 mm Hg – after 4 and 12 weeks (51,3% vs 43,5% (p=0,041) and 74,9% vs 67,5% (p=0,038), respectively). Left ventricular hypertrophy was a significant negative predictor of SBP reduction by 12 weeks of therapy, and the presence of grade 2 hypertension (HTN) and statin use, on the contrary, were positive predictors of changes in SBP by the end of observation. More adherent younger patients were significantly more likely to have a decrease in DBP by 12 weeks of follow-up. In addition, in young patients, male sex and the presence of dyslipidemia significantly increased the chances of blood pressure control at the end of observation. Waist circumference, body mass index, and grade 2 HTN were negative predictors of achieving the target blood pressure level.Conclusion. Thus, in young patients, good antihypertensive effectiveness of amlodipine/indapamide/perindopril was observed, comparable in the degree of blood pressure reduction with the older age group of 50 years and older.https://russjcardiol.elpub.ru/jour/article/view/5597arterial hypertensionyoung patientstriple fixed-dose combinationamlodipine/indapamide/perindopril
spellingShingle Yu. A. Karpov
N. A. Logunova
B. B. Kvasnikov
Yu. V. Khomitskaya
New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
Российский кардиологический журнал
arterial hypertension
young patients
triple fixed-dose combination
amlodipine/indapamide/perindopril
title New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
title_full New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
title_fullStr New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
title_full_unstemmed New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
title_short New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
title_sort new data from a subanalysis of the tricolor study antihypertensive effectiveness of the triple single pill combination of amlodipine indapamide perindopril and predictors of effectiveness and blood pressure control in young patients
topic arterial hypertension
young patients
triple fixed-dose combination
amlodipine/indapamide/perindopril
url https://russjcardiol.elpub.ru/jour/article/view/5597
work_keys_str_mv AT yuakarpov newdatafromasubanalysisofthetricolorstudyantihypertensiveeffectivenessofthetriplesinglepillcombinationofamlodipineindapamideperindoprilandpredictorsofeffectivenessandbloodpressurecontrolinyoungpatients
AT nalogunova newdatafromasubanalysisofthetricolorstudyantihypertensiveeffectivenessofthetriplesinglepillcombinationofamlodipineindapamideperindoprilandpredictorsofeffectivenessandbloodpressurecontrolinyoungpatients
AT bbkvasnikov newdatafromasubanalysisofthetricolorstudyantihypertensiveeffectivenessofthetriplesinglepillcombinationofamlodipineindapamideperindoprilandpredictorsofeffectivenessandbloodpressurecontrolinyoungpatients
AT yuvkhomitskaya newdatafromasubanalysisofthetricolorstudyantihypertensiveeffectivenessofthetriplesinglepillcombinationofamlodipineindapamideperindoprilandpredictorsofeffectivenessandbloodpressurecontrolinyoungpatients